Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History

Group One Trading’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161K	Sell	500 -15,700	-97%	-$4.86M	﹤0.01%	4297
2025 Q4	$4.77M	Sell	16,200 -4,400	-21%	-$819K	0.01%	1541
2025 Q3	$1.09M	Buy	20,600 +17,400	+544%	+$844K	﹤0.01%	2938
2025 Q2	$135K	Sell	3,200 -33,000	-91%	-$1.26M	﹤0.01%	4711
2025 Q1	$1.37M	Buy	36,200 +9,300	+35%	+$581K	﹤0.01%	2175
2024 Q4	$2.07M	Sell	26,900 -18,600	-41%	-$1.35M	﹤0.01%	1883
2024 Q3	$2.62M	Buy	+45,500	New	+$2.46M	0.01%	1508
2023 Q2	–	Sell	-2,940	Closed	-$35.7K	–	8093
2023 Q1	$35.7K	Buy	+2,940	New	+$124K	﹤0.01%	5110

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Group One Trading's PRAX Position: Q1 2026 in Review

Group One Trading reduced its Praxis Precision Medicines (PRAX) stake by 98% in Q1 2026, selling an estimated $1.67M and leaving 129 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.

Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 13 quarters since. The position peaked at $3.5M in Q3 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Group One Trading held 129 shares of Praxis Precision Medicines worth $41.6K as of Q1 2026.
Group One Trading sold 5,410 Praxis Precision Medicines shares in Q1 2026, an estimated $1.67M.
Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5395 holding.
Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 13 quarters since.
Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.